-Newsclick.in A few weeks back Fortune magazine and CNN carried a long online blog titled ‘Dirty Medicine' by Dinesh Thakur, a former employ of Ranbaxy, where he recounts how he came across several procedural and other lapses in the company's manufacturing facilities. Since then the Fortune blog has become one of the most widely circulated and commented upon business stories in the world. The story received attention as it came in the...

-The Times of India MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say. Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for...

-The Indian Express Trendsetters & tweakers Act one Chhattisgarh already has a food security law in place. It became last December the first state to pass a food security bill, which covers several sections not under existing schemes. The Act makes food entitlement a right and depriving anyone of that an offence. If PDS grains, for instance, are being diverted, the officials involved will face penal provisions. The Act also seeks to empower women...

-The Hindu     The national culture of unquestioned obedience to authority along with an acceptance of shoddiness must not be used as an excuse to overlook violations of corporate ethics, says the Ranbaxy whistle-blower During my tenure at Ranbaxy, I was surprised by the unchallenged conformity to the poor decisions of senior leadership. Ranbaxy was my first Indian employer following my tenure at two different American corporations. Reflecting on this experience from cultural...

-PTI Drug regulator DGCI is conducting a "focussed scrutiny" of medicines sold by Ranbaxy and some other drug makers, but says it remains confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products. While the company continues to assert that its drugs meet all regulatory standards, a few hospitals and pharmacies have adopted a cautious stand on use of its products. However, a majority...